Skip to main content
OpenTrials

Clinical trial condition

Renal Cell Carcinoma

Explore clinical trials studying Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.

412 public trials 75 recruiting studies
Refine in advanced search Browse all conditions

Renal Cell Carcinoma trial results

Completed

A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) as Monotherapy or in Combination With Bevacizumab (Avastin®) Compared to Sunitinib (Sutent®) in Participants With Untreated Advanced Renal Cell Carcinoma

NCT01984242

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • HonorHealth Research Institute - Bisgrove Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCLA Los Angeles, California, United States
  • University of California San Francisco, California, United States
View all 45 locations
View Trial Details
Completed

Observational Study Evaluating The Efficacy And Effects On Quality Of Life Of Targeted Treatments Following TKIs In mRCC

NCT02315755

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Gazi University Ankara, Besevler, Turkey (Türkiye)
  • Abdurrahman Yurtaslan Onkoloji Hastanesi Ankara, Demetevler, Turkey (Türkiye)
  • Marmara Üniversitesi Pendik Eğtim Araştırma Hastanesi Pendik, İ̇stanbul, Turkey (Türkiye)
  • Hacettepe University School of Medicine, Department of Medical Oncology Ankara, Turkey (Türkiye)
View all 19 locations
View Trial Details

Related conditions